Skip to content

Clinical trials

Observational Pulmonary Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Observational Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20062
20082
20102
20112
20133
20142
20183
20201
20215
20224
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting9
Unknown status6
Active, not recruiting4
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)6
National Human Genome Research Institute (NHGRI)4
National Jewish Health4
Pulmonary Care and Research Collaborative Limited3
Northwestern University2
University of California, San Francisco2
University of Pittsburgh2
23andMe, Inc.1
Columbia University1
Corewell Health East1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis38
Lung Diseases, Interstitial16
Idiopathic Pulmonary Fibrosis13
Lung Diseases6
Sarcoidosis6
Alveolitis, Extrinsic Allergic4
Hermanski-Pudlak Syndrome4
Arthritis, Rheumatoid3
Asthma3
Cystic Fibrosis3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.